loadpatents
name:-0.014354944229126
name:-0.01265811920166
name:-0.0026249885559082
Martinez; Michelle Patent Filings

Martinez; Michelle

Patent Applications and Registrations

Patent applications and USPTO patent grants for Martinez; Michelle.The latest application filed is for "suture lock device".

Company Profile
2.15.19
  • Martinez; Michelle - Winston Salem NC
  • Martinez; Michelle - Watertown MA
  • Martinez; Michelle - Medford MA US
  • Martinez; Michelle - Salem MA US
  • Martinez; Michelle - Clearwater FL
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Suture lock device
Grant 11,439,384 - Gittard , et al. September 13, 2
2022-09-13
Suture Lock Device
App 20190247043 - Gittard; Shaun Davis ;   et al.
2019-08-15
Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitors
Grant 9,957,264 - Childers , et al. May 1, 2
2018-05-01
Mitral Prolapse Valve Restrictor
App 20170354500 - Martinez; Michelle ;   et al.
2017-12-14
2,6,7 substituted purines as HDM2 inhibitors
Grant 9,682,978 - Christopher , et al. June 20, 2
2017-06-20
2,6,7,8 substituted purines as HDM2 inhibitors
Grant 9,540,377 - Cammarano , et al. January 10, 2
2017-01-10
Acyclic cyanoethylpyrazoles as janus kinase inhibitors
Grant 9,493,441 - Brubaker , et al. November 15, 2
2016-11-15
Geminally Substituted Cyanoethylpyrazolo Pyridones As Janus Kinase Inhibitors
App 20160272632 - Childers; Matthew Lloyd ;   et al.
2016-09-22
2,6,7 Substituted Purines As Hdm2 Inhibitors
App 20150368247 - Christopher; Matthew P. ;   et al.
2015-12-24
2,6,7,8 Substituted Purines As Hdm2 Inhibitors
App 20150353553 - Cammarano; Carolyn Michele ;   et al.
2015-12-10
Substituted imidazopyridines as HDM2 inhibitors
Grant 8,962,611 - Christopher , et al. February 24, 2
2015-02-24
Bicyclic diamines as janus kinase inhibitors
Grant 8,937,077 - Guerin , et al. January 20, 2
2015-01-20
Substituted Imidazopyridines As Hdm2 Inhibitors
App 20140357618 - Christopher; Matthew P. ;   et al.
2014-12-04
Substituted imidazopyridines as HDM2 inhibitors
Grant 8,846,657 - Christopher , et al. September 30, 2
2014-09-30
Acyclic Cyanoethylpyrazoles As Janus Kinase Inhibitors
App 20140228358 - Brubaker; Jason ;   et al.
2014-08-14
Substituted Imidazopyridines as HDM2 Inhibitors
App 20140179680 - Christopher; Matthew P. ;   et al.
2014-06-26
Cycloalkyl-fused Tetrahydroquinolines As Crth2 Receptor Modulators
App 20140128367 - Huang; Xianhai ;   et al.
2014-05-08
Cycloalkyl-fused tetrahydroquinolines as CRTH.sub.2 receptor modulators
Grant 8,592,383 - Huang , et al. November 26, 2
2013-11-26
Bicyclic Diamines As Janus Kinase Inhibitors
App 20130225577 - Guerin; David Joseph ;   et al.
2013-08-29
Silylated piperidine derivatives
Grant 8,420,622 - Munoz , et al. April 16, 2
2013-04-16
Cycloalkyl-fused Tetrahydroquinolines As Crth2 Receptor Modulators
App 20120329743 - Huang; Xianhai ;   et al.
2012-12-27
Tyrosine Kinase Inhibitors
App 20120264735 - Young; Jonathan ;   et al.
2012-10-18
Purine Derivatives For Treatment Of Alzheimer's Disease
App 20110251172 - Rivkin; Alexey A. ;   et al.
2011-10-13
Silylated Piperidine Derivatives
App 20100093665 - Munoz; Benito ;   et al.
2010-04-15
System and method for the implicit support of IP subnetworks
Grant 6,085,245 - Kaycee , et al. July 4, 2
2000-07-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed